Versant Capital Management, Inc

Position in RGNX — REGENXBIO Inc.

CIK 1735057 PHOENIX, AZ

Position in RGNX

as of Jun 30, 2026 · filed Jul 2, 2026 Compact

Position Value

$32,837

+$18,516 QoQ

Shares Held

2,741

+60.4% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#122

of 164 holders

Holding Since

Mar 2022

17 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Versant Capital Management, Inc holds $5,555,601 across 126 Biotechnology names. RGNX ranks #34 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JAZZ	Jazz Pharmaceuticals plc	2,357	$567,966
2	VRTX	Vertex Pharmaceuticals Inc / Ma	1,055	$524,050
3	ARGX	Argenx SE	419	$388,735
4	GMAB	Genmab A/S	11,712	$321,728
5	REGN	Regeneron Pharmaceuticals, Inc.	344	$214,497
6	CELC	Celcuity Inc.	1,630	$170,530
7	MRNA	Moderna, Inc.	2,189	$153,295
8	BMRN	Biomarin Pharmaceutical Inc	2,549	$145,853

17 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$32,837	2,741	+60.4%	Shares	Sole	2026-07-02
2026-03-31	$14,321	1,709	0.0%	Shares	Sole	2026-04-07
2025-12-31	$24,609	1,709	0.0%	Shares	Sole	2026-01-08
2025-09-30	$16,491	1,709	+662.9%	Shares	Sole	2025-10-27
2025-06-30	$1,839	224	-89.0%	Shares	Sole	2025-07-07
2025-03-31	$14,557	2,036	+45.3%	Shares	Sole	2025-04-03
2024-12-31	$10,829	1,401	+26.2%	Shares	Sole	2025-01-03
2024-09-30	$11,643	1,110	+3727.6%	Shares	Sole	2024-10-07
2024-06-30	$339	29	0.0%	Shares	Sole	2024-07-08
2024-03-31	$611	29	0.0%	Shares	Sole	2024-04-03
2023-12-31	$520	29	0.0%	Shares	Sole	2024-01-08
2023-09-30	$477	29	-47.3%	Shares	Sole	2023-10-12
2023-06-30	$1,099	55	+89.7%	Shares	Sole	2023-07-10
2023-03-31	$548	29	0.0%	Shares	Sole	2023-04-10
2022-12-31	$657	29	-88.0%	Shares	Sole	2023-01-25
2022-09-30	$6,396	242	+272.3%	Shares	Sole	2022-12-30
2022-03-31	$2,157	65	—	Shares	Sole	2022-04-29
No filing history on record for this holder in this stock.